State Street Corp Tg Therapeutics, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 7,618,238 shares of TGTX stock, worth $207 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,618,238
Previous 7,433,899
2.48%
Holding current value
$207 Million
Previous $293 Million
6.46%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding TGTX
# of Institutions
405Shares Held
92.3MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$309 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$94.7 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$82.8 Million0.09% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.24MShares$60.9 Million6.26% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.94B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...